GAIN THERAPEUTICS, INC Payments to Acquire Productive Assets
GAIN THERAPEUTICS, INC (GANX) reported Payments to Acquire Productive Assets of $22.49 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2026-03-26
- GAIN THERAPEUTICS, INC payments to acquire productive assets for the quarter ending 2024-12-31 was $945.00, a 4873.68% increase year-over-year.
- GAIN THERAPEUTICS, INC payments to acquire productive assets for the quarter ending 2024-09-30 was $1.00, a 99.85% decline year-over-year.
- GAIN THERAPEUTICS, INC payments to acquire productive assets for the quarter ending 2023-12-31 was $19.00, a 99.80% decline year-over-year.
- GAIN THERAPEUTICS, INC payments to acquire productive assets for the quarter ending 2023-09-30 was $650.00, a 98.86% decline year-over-year.
- GAIN THERAPEUTICS, INC payments to acquire productive assets for fiscal 2024 was $22.49K, a 46.46% increase from fiscal 2023.
- GAIN THERAPEUTICS, INC payments to acquire productive assets for fiscal 2023 was $15.36K, a 87.09% decline from fiscal 2022.
- GAIN THERAPEUTICS, INC payments to acquire productive assets for fiscal 2022 was $118.95K, a 26.26% increase from fiscal 2021.
- GAIN THERAPEUTICS, INC payments to acquire productive assets for fiscal 2021 was $94.21K.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 12 month |
|---|---|---|---|---|
| 2024-12-31 | $945.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $946.00 derived: sum of 2 quarters · filed 2026-03-26 | $22.49K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $21.55K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $21.55K 10-Q · filed 2025-08-12 | |||
| 2023-12-31 | $19.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $669.00 derived: sum of 2 quarters · filed 2025-03-27 | $4.31K derived: sum of 3 quarters · filed 2025-03-27 | $15.36K 10-K · filed 2025-03-27 |
| 2023-09-30 | $650.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $4.29K derived: sum of 2 quarters · filed 2024-11-14 | $15.34K 10-Q · filed 2024-11-14 | $24.74K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $3.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $14.69K 10-Q · filed 2024-08-08 | $24.09K derived: sum of 3 quarters · filed 2024-08-08 | $81.27K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $11.04K 10-Q · filed 2024-05-14 | $20.44K derived: sum of 2 quarters · filed 2024-05-14 | $77.62K derived: sum of 3 quarters · filed 2024-05-14 | $122.17K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $9.40K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $66.58K derived: sum of 2 quarters · filed 2024-03-26 | $111.13K derived: sum of 3 quarters · filed 2024-03-26 | $118.95K 10-K · filed 2024-03-26 |
| 2022-09-30 | $57.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $101.73K derived: sum of 2 quarters · filed 2023-11-14 | $109.56K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $44.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $52.38K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $7.83K 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | $94.21K 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |